← Product Code [JIS](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIS) · K122126

# DIRECT LDL/HDL CHOLESTEROL CALIBRATOR (K122126)

_Randox Laboratories Limited · JIS · Aug 14, 2012 · Clinical Chemistry · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIS/K122126

## Device Facts

- **Applicant:** Randox Laboratories Limited
- **Product Code:** [JIS](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIS.md)
- **Decision Date:** Aug 14, 2012
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 862.1150
- **Device Class:** Class 2
- **Review Panel:** Clinical Chemistry

## Indications for Use

The Randox Direct LDL/HDL Cholesterol Calibrator is intended for in vitro diagnostic use in the calibration of Randox HDL and LDL Cholesterol methods. This in vitro diagnostic device is intended for prescription use only and can only be used by professionals.

## Device Story

Randox Direct LDL/HDL Cholesterol Calibrator is a lyophilized human serum-based calibrator containing LDL and HDL lipoproteins. Used in clinical laboratories by professionals to calibrate Randox HDL and LDL cholesterol assay methods. The calibrator is supplied in 3x1ml vials; requires reconstitution before use. Assigned values are established on multiple analyzers (e.g., Abbott Architect, Beckman Coulter AU, Hitachi, Randox RX series, Siemens Advia) relative to a master lot. Provides standardized reference points for clinical chemistry analyzers to ensure accurate patient sample quantification. Benefits patient care by ensuring the accuracy and reliability of cholesterol testing, which is critical for lipid profile assessment and cardiovascular risk management.

## Clinical Evidence

Bench testing only. Stability studies confirmed performance of the calibrator under specified storage conditions (unopened at 2-8°C; reconstituted at 2-8°C for 5 days or -20°C for 1 month). Value assignment was validated across multiple clinical analyzer platforms.

## Technological Characteristics

Lyophilized human serum matrix containing LDL and HDL lipoproteins. Form factor: 3x1ml vials. Storage: 2-8°C. Stability: 5 days post-reconstitution at 2-8°C. No electronic components, software, or energy sources.

## Regulatory Identification

A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)

## Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

Decision Summary, k122126

This 510(k) was reviewed under OIVD’s Pilot Triage Program. This program represents an internal workload management tool intended to reduce internal FDA review resources for 510(k) applications that are of good quality upon receipt by FDA.

The information in the 510(k) is complete and supports a substantial equivalence (SE) determination. Please refer to the applicant’s 510(k) summary for a summary of the information that supports this SE determination.

OIVD, 4/2/12, v1.1

---

**Source:** [https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIS/K122126](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIS/K122126)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com